The US Food and Drug Administration is undergoing the biggest reorganization in its history, according to commissioner Robert Califf, who provided updates on the some of the agency’s latest moves during a recent Alliance for a Stronger FDA webinar.
As part of its restructuring effort, the agency’s Office of Regulatory Affairs (ORA) will focus on what Califf called the “three I’s: inspections, investigations, and imports.”
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?